# Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study

> **NCT03067974** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Arizona** · enrollment: 10 (actual)

## Conditions studied

- Failed Moderate Sedation During Procedure
- Ketamine Adverse Reaction

## Interventions

- **DRUG:** Ketamine Hcl 100Mg/Ml Inj

## Key facts

- **NCT ID:** NCT03067974
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-21
- **Primary completion:** 2019-01-22
- **Final completion:** 2019-01-22
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Initial results did not show benefit.
- **Last updated:** 2019-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03067974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03067974, "Intranasal Ketamine for Pediatric Procedural Sedation: a Feasibility Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03067974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*